TTR Amyloidosis: What Clinicians Need to Know About Its Pathophysiology

TTR Amyloidosis: What Clinicians Need to Know About Its Pathophysiology is organized by American Academy of CME, Inc.

Release date: 11/30/19
Expiration date: 11/30/20

Accreditation:
American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program: TTR Amyloidosis

Course Description:
By learning more about the pathophysiology of rare diseases like TTR Amyloidosis, members of the care team who may encounter these patients on their diagnostic journeys can have a profound impact on their ultimate outcomes.

Learning Objective:
After participating in the activity, learners should be better able to:
• Describe the epidemiology and pathophysiology of TTR amyloidosis

Additional details will be posted as soon as information is available.